Christina Swärd

456 total citations
10 papers, 340 citations indexed

About

Christina Swärd is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Christina Swärd has authored 10 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Oncology and 5 papers in Neurology. Recurrent topics in Christina Swärd's work include Neuroendocrine Tumor Research Advances (8 papers), Neuroblastoma Research and Treatments (5 papers) and Lung Cancer Research Studies (5 papers). Christina Swärd is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Neuroblastoma Research and Treatments (5 papers) and Lung Cancer Research Studies (5 papers). Christina Swärd collaborates with scholars based in Sweden. Christina Swärd's co-authors include Ola Nilsson, Håkan Ahlman, Bo Wängberg, Lars Kölby, Peter Bernhardt, Viktor Johanson, Eva Forssell‐Aronsson, Yvonne Arvidsson, Göran Stenman and Erik Kristiansson and has published in prestigious journals such as British journal of surgery, Neuroscience Letters and World Journal of Surgery.

In The Last Decade

Christina Swärd

10 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christina Swärd Sweden 10 256 239 158 50 41 10 340
Véronique Eltschinger Switzerland 7 258 1.0× 220 0.9× 109 0.7× 82 1.6× 176 4.3× 7 385
S. Cassetta Italy 4 341 1.3× 323 1.4× 215 1.4× 27 0.5× 13 0.3× 5 392
Barbara Janota Poland 8 234 0.9× 196 0.8× 117 0.7× 25 0.5× 115 2.8× 16 319
Lily Jih United States 8 314 1.2× 290 1.2× 192 1.2× 153 3.1× 5 0.1× 16 502
Heleen Visser-Wisselaar Netherlands 9 130 0.5× 93 0.4× 40 0.3× 75 1.5× 50 1.2× 18 283
Jacques-Pierre Moreau France 6 150 0.6× 100 0.4× 50 0.3× 121 2.4× 32 0.8× 6 337
Sara Ekeblad Sweden 8 644 2.5× 593 2.5× 459 2.9× 49 1.0× 3 0.1× 9 749
Ofra Maimon Israel 8 119 0.5× 122 0.5× 96 0.6× 39 0.8× 22 0.5× 23 291
F Robiller Germany 4 134 0.5× 283 1.2× 79 0.5× 36 0.7× 117 2.9× 10 364
Elza de Bruin United Kingdom 7 72 0.3× 87 0.4× 40 0.3× 64 1.3× 53 1.3× 11 195

Countries citing papers authored by Christina Swärd

Since Specialization
Citations

This map shows the geographic impact of Christina Swärd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Swärd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Swärd more than expected).

Fields of papers citing papers by Christina Swärd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Swärd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Swärd. The network helps show where Christina Swärd may publish in the future.

Co-authorship network of co-authors of Christina Swärd

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Swärd. A scholar is included among the top collaborators of Christina Swärd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Swärd. Christina Swärd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Arvidsson, Yvonne, Anders Bergström, Christina Swärd, et al.. (2018). miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival. Modern Pathology. 31(8). 1302–1317. 39 indexed citations
3.
Swärd, Christina, Peter Bernhardt, Håkan Ahlman, et al.. (2010). [177Lu‐DOTA0‐Tyr3]‐Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed Dose to the Kidney. World Journal of Surgery. 34(6). 1368–1372. 50 indexed citations
4.
Swärd, Christina, et al.. (2009). High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids. Endocrine Related Cancer. 16(3). 953–966. 60 indexed citations
5.
Swärd, Christina, Viktor Johanson, Els Nieveen van Dijkum, et al.. (2009). Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome. British journal of surgery. 96(5). 517–521. 36 indexed citations
6.
Swärd, Christina, Peter Bernhardt, Viktor Johanson, et al.. (2008). Comparison of [ 177 Lu-DOTA 0 ,Tyr 3 ]-Octreotate and [ 177 Lu-DOTA 0 ,Tyr 3 ]-Octreotide for Receptor-Mediated Radiation Therapy of the Xenografted Human Midgut Carcinoid Tumor GOT1. Cancer Biotherapy and Radiopharmaceuticals. 23(1). 114–120. 24 indexed citations
7.
Johanson, Viktor, Håkan Ahlman, Peter Bernhardt, et al.. (2007). A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis. Endocrine Related Cancer. 14(2). 433–444. 22 indexed citations
8.
Johanson, Viktor, Yvonne Arvidsson, Lars Kölby, et al.. (2005). Antitumoural Effects of the Pyridyl Cyanoguanidine CHS 828 on Three Different Types of Neuroendocrine Tumours Xenografted to Nude Mice. Neuroendocrinology. 82(3-4). 171–176. 20 indexed citations
9.
Kölby, Lars, Peter Bernhardt, Christina Swärd, et al.. (2004). Chromogranin A as a determinant of midgut carcinoid tumour volume. Regulatory Peptides. 120(1-3). 269–273. 41 indexed citations
10.
Swärd, Christina, et al.. (1995). Axonal constriction at Ranvier's node increases during development. Neuroscience Letters. 190(3). 159–162. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026